Passage Bio, Inc. (PASG) financial statements (2022 and earlier)

Company profile

Business Address ONE COMMERCE SQUARE
PHILADELPHIA, PA 19103
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments315,773304,817
Cash and cash equivalents128,965135,002
Short-term investments186,808169,815
Prepaid expense 1,405
Deferred costs 200
Other undisclosed current assets9,29310,761
Total current assets:325,066317,183
Noncurrent Assets
Property, plant and equipment23,8062,795
Other noncurrent assets6,2048,029
Total noncurrent assets:30,01010,824
TOTAL ASSETS:355,076328,007
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities20,33911,168
Accounts payable9,4485,265
Accrued liabilities877720
Employee-related liabilities10,0145,183
Other liabilities500541
Other undisclosed current liabilities8,6599,466
Total current liabilities:29,49821,175
Noncurrent Liabilities
Liabilities, other than long-term debt6,9212,118
Deferred rent credit6,9212,077
Other liabilities 41
Total noncurrent liabilities:6,9212,118
Total liabilities:36,41923,293
Stockholders' equity
Stockholders' equity attributable to parent318,657304,714
Common stock54
Additional paid in capital675,346475,617
Accumulated other comprehensive loss(413)(12)
Accumulated deficit(356,281)(170,895)
Total stockholders' equity:318,657304,714
TOTAL LIABILITIES AND EQUITY:355,076328,007

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Operating expenses(185,729)(112,902)
Operating loss:(185,729)(112,902)
Nonoperating income
(Investment Income, Nonoperating)
343670
Net loss available to common stockholders, diluted:(185,386)(112,232)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(185,386)(112,232)
Comprehensive loss:(185,386)(112,232)
Other undisclosed comprehensive loss, net of tax, attributable to parent(401)(12)
Comprehensive loss, net of tax, attributable to parent:(185,787)(112,244)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: